4 Hrs
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
4 Hrsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
4 HrsReady to play
Ready to play
A study has identified a molecular signal in the blood that may help detect changes preceding ovarian cancer by measuring a molecule called “TO-STROMA,” which is associated with microscopic changes in the fallopian tubes. The test detected these changes in 92.3% of women who had them and correctly identified 98.2% of healthy women. Among women with inherited risk factors, the true-positive rate was about 72%, while the accuracy of negative results was close to 100%. The researchers described the discovery as a promising step toward developing early detection.
Notice: This Is an AI-Generated Summary
Comments (0)